Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02493491 · ClinicalTrials.gov registry record
Neurogenic Dysphonia/Dysphagia Registry
A clinical trial, sponsored by Merz North America.
- Terminated
- Registry status
- 146
- Enrollment target
NCT02493491 is a clinical trial that was terminated before completion, run by Merz North America. The registered enrollment target is 146 participants.
The verdict
NCT02493491 was terminated before completion, sponsored by Merz North America.
- TERMINATED
- Registry status
- 146 participants
- Enrollment target
Study Summary
The Neurogenic Dysphonia/Dysphagia Registry is designed to be purely observational (i.e. non-interventional, exploratory). Patient data collected from the registry is expected to be consistent with any information which can be obtained during usual care of patients with dysphonia/dysphagia treated with vocal fold augmentation.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 146 participants |
| Start Date | 2015-06 |
| Est. Completion | 2016-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02493491
The ClinicalTrials.gov registry entry for NCT02493491 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 146 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Merz North America, which has 35 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02493491 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02493491 about?
NCT02493491 is a clinical study titled "Neurogenic Dysphonia/Dysphagia Registry". The Neurogenic Dysphonia/Dysphagia Registry is designed to be purely observational (i.e. non-interventional, exploratory). Patient data collected from the registry is expected to be consistent with any information which can be obtained during usual care of patients with dysphonia/dysphagia treated w...
What is the current status of trial NCT02493491?
This trial is currently terminated. The enrollment target is 146 participants. The study started on 2015-06. Estimated completion is 2016-09.
Who is sponsoring clinical trial NCT02493491?
This trial is sponsored by Merz North America, which has 35 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.